Home - Products - Others - Other Targets - Ethyl 3,4,5-trimethoxybenzoate

Ethyl 3,4,5-trimethoxybenzoate

CAS No. 6178-44-5

Ethyl 3,4,5-trimethoxybenzoate( —— )

Catalog No. M31366 CAS No. 6178-44-5

Ethyl 3,4,5-trimethoxybenzoate is a natural product from Rauvolfia verticillata.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl 3,4,5-trimethoxybenzoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl 3,4,5-trimethoxybenzoate is a natural product from Rauvolfia verticillata.
  • Description
    Ethyl 3,4,5-trimethoxybenzoate is a natural product from Rauvolfia verticillata.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6178-44-5
  • Formula Weight
    240.3
  • Molecular Formula
    C12H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 6-NBDG

    6-NBDG, a fluorescent glucose analogue, can be used as a fluorescent probe.6-NBDG can be used for monitoring glucose transport and uptake. 6-NBDG can be used as for detecting macrophage-rich atherosclerotic plaques.

  • [Pyr3]-Amyloid β-Pro...

    Amyloid β-Protein (3-42) is the precursor of Pyr peptide. Pyroglutamate-modified Aβ (pEAβ) (3-42) is the core of the amyloid template block in Alzheimer's disease. pEAβ(3-42) accelerated the aggregation of Aβ(1-42), while Aβ(1-42) significantly slowed the primary and secondary nucleation of pEAβ(3-42).

  • ADWX 1

    Potent and selective KV1.3 channel blocker (IC50 values are 0.0019 and 0.65 nM for KV1.3 and KV1.1, respectively). Inhibits CD4+ CCR7- T cell activation. Ameliorates rat experimental autoimmune encephalomyelitis, in a model for multiple sclerosis.